Sarah A. Figley
Affiliations: | Institute of Medical Science | University of Toronto, Toronto, ON, Canada |
Area:
Neuroprotection, Neuroregeneration, Spinal Cord, Growth FactorsGoogle:
"Sarah Figley"Mean distance: 106866 (cluster 23) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Figley SA, Liu Y, Karadimas SK, et al. (2014) Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. Plos One. 9: e96137 |
Figley SA, Khosravi R, Legasto JM, et al. (2014) Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. Journal of Neurotrauma. 31: 541-52 |
Figley SA, Liu Y, Karadimas SK, et al. (2014) AdV-ZFP-VEGF does not improve open-field walking (BBB) scores following SCI. Plos One |
Figley SA, Chen Y, Maeda A, et al. (2013) A spinal cord window chamber model for in vivo longitudinal multimodal optical and acoustic imaging in a murine model. Plos One. 8: e58081 |
Ye H, Buttigieg J, Wan Y, et al. (2012) Expression and functional role of BK channels in chronically injured spinal cord white matter. Neurobiology of Disease. 47: 225-36 |
Liu Y, Figley S, Spratt SK, et al. (2009) An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiology of Disease. 37: 384-93 |